Research News

Brain tumour research is advancing around the world and this page highlights other recent breakthroughs.

Please note that these articles are provided for information only and any questions should be directed to your doctor.

Research News

April 2021 – UAB research: Modified herpes virus shows promise in treating pediatric brain tumors
“A modified herpes virus, alone and in combination with radiation, has been shown to be well tolerated with early signs of clinical effectiveness in pediatric patients with high-grade brain tumors, or gliomas, according to findings from researchers at the University of Alabama at Birmingham and Children’s of Alabama.”


March 2021 – Chemo for glioblastoma may work better in morning than evening
Patients treated with Temozolomide in the morning are experiencing longer survival rates than those who receive their treatment in the evening, studies show.


March 2021 – Hydrogel used to revert cancer cells back to cancer stem cells
A hydrogel developed at Hokkaido University, Japan, successfully reverted cancer cells back to cancer stem cells within 24 hours, in six different human cancer types.


March 2021 – The Tumour Microenvironment: Local Effects With Widespread Consequences
Despite the fact that the Tumour Micro-Environment (TME) develops locally, as its name suggests, it has important and far-reaching consequences.


March 2021 – Nascent Biotech Opens Phase 1 Human Trial to Evaluate Pritumumab as Treatment Option for Primary and Metastatic Brain Cancer


March 2021 – Pediatric brain tumours can be classified using diffusion weighted imaging and machine learning
Diffusion weighted imaging and machine learning can successfully classify the diagnosis and characteristics of common types of pediatric brain tumours.


March 2021 – Sydney Researchers Identify Potential New Drug Treatment Developed by Aminex Therapeutics for Fatal Childhood Cancer
A new drug combination has shown ‘spectacularly effective’ results against DIPG in animal and 3D model testing.


March 2021 – New immunotherapy target discovered for malignant brain tumours
Scientists say they have discovered a potential new target for immunotherapy of malignant brain tumours – the CD161 molecule.


March 2021 – Brain tumours and COVID-19: the patient and caregiver experience
This is the first international survey completed with the purpose of identifying brain tumour patient and caregiver concerns due to COVID-19.


March 2021 –

Promising new approach to stop growth of brain cancer cells
“Researchers at Princess Margaret Cancer Centre, the Hospital for Sick Children (SickKids) and University of Toronto, showed that chemically inhibiting the enzyme PRMT5 can suppress the growth of glioblastoma cells.”


March 2021 – World-first study highlights potential of focused ultrasound in the detection of brain cancer biomarkers through liquid biopsy
“In a first-ever study, Sunnybrook researchers have demonstrated that MRI-guided focused ultrasound technology can improve the detection of brain cancer biomarkers with the temporary opening of the blood-brain barrier to aid liquid biopsy.”


March 2021 – This US startup is building tiny injectable robots to attack tumours
Science fiction come to life – California-based Bionaut Labs is aiming to be the first to create remote-controlled robots that can be implanted to tackle tumours. The goal is clinical trials by 2023.


March 2021 – UWindsor chemist designs alternate treatment for brain cancer
John Trant received a research grant of $50,000 from Brain Tumour Foundation of Canada to assist his work into nanoparticles that can get past the blood-brain barrier.


March 2021 – Medexus Announces Expanded Availability of Gleolan in Canada
After limited availability through Health Canada’s special access program, Gleolan is now available commercially in Canada. The imaging agent aids surgeons in the resection of brain tumours by making tumour tissue glow a different colour than normal, healthy brain tissue.


February 2021 – Kintara Therapeutics enrolls last patient in Phase 2 VAL-083 trial for recurrent glioblastoma multiforme
Kintara Therapeutics Inc has enrolled the final patient in the recurrent arm of its ongoing Phase 2 clinical glioblastoma multiforme (GBM) study of its VAL-083 drug.


February 2021 – Setting international standards in analyzing patient-reported outcomes and QOL endpoints
“An international multidisciplinary consortium, co-led by the European Organisation for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has been convened to generate recommendations to standardize the use, analysis, and interpretation of patient reported outcome (PRO) data in cancer clinical trials.”


February 2021 – Researchers find potential new treatment for fatal childhood brain cancer
Researchers in Australia are reporting promising new findings to treat Diffuse Intrinsic Pontine Glioma (DIPG).


February 2021 – New drug targets for childhood cancer neuroblastoma identified
The discovery of a single cell behind childhood neuroblastoma has created new drug treatment opportunities.


February 2021 – Prolonged high dose use of hormone drug linked to increased brain tumour risk in women
A French study of more than 250,000 women has shown the drug cyproterone acetate is associated with an increased risk of developing a brain tumour.


January 2021 – Montreal researcher’s work could identify children at risk for cancer
“The work of a Montreal researcher could lead to identifying which children have a genetic predisposition to cancer, allowing them to be closely monitored and, hopefully, lead to an early diagnosis of the disease.”


January 2021 – Multimodal spectroscopy detects brain tumours in vivo
“Researchers in Italy have performed a proof-of-concept study showing that a combination of three different optical spectroscopic techniques has potential to improve the in vivo detection and delineation of malignant brain tumours and to guide their surgical removal.”


December 2020 – Brain cancer linked to tissue healing: U of T researchers
“The healing process that follows a brain injury – from trauma to infection and stroke – could spur tumour growth.”


December 2020 –
Anti-diarrhea drug may treat same type of brain cancer that killed Gord Downie: study
“A research group in at Goethe University Frankfurt found that the drug loperamide, sometimes sold under the brand name Imodium, can be used to induce cell death in glioblastoma cell lines.”


December 2020 –
Researchers identify the origin of a deadly brain cancer News
A research team from McGill University have discovered a gene needed for tumour growth for a subgroup of glioblastoma that affects teens and young adults – providing an important first step towards more effective treatment.


December 2020 –
Why Tumor Necrosis Might Not Be Good News for Some Patients With Glioblastoma
Researchers at Penn State College of Medicine have said that higher amounts of tissue death brought on by certain white blood cells have been associated with poor survival in patients with aggressive glioblastomas.


December 2020 –
Kazia Therapeutics’ (ASX:KZA) brain cancer drug selected for international study
Kazia Therapeutics’ (KZA) paxalisib drug has been chosen for a multiple-therapy clinical trial in diffuse midline glioma.”


December 2020 –
New guidelines for treating the complications of brain tumours
An international team of researchers has now compiled international guidelines and standards for the treatment of common brain tumour complications.


November 2020 –
Is proton therapy the silver bullet for children with brain cancer?
A new study from the University of South Australia explores the efficacy of proton therapy in children with brain tumours.


November 2020 –
Novel nanoparticle therapy shows promise in glioblastoma
“The synthetic protein nanoparticle can cross the blood-brain barrier and deliver a targeted therapeutic to glioblastoma cells, say researchers.”


October 2020 – Next generation BRAF inhibitor cancer drug shows promise in early patient trial

A new drug designed to work on cancers with an altered BRAF gene has shown promise in an early patient trial.


October 2020 – University of Calgary researchers discover new tactic to stop the growth of a deadly brain cancer: Findings indicate the body may be the ultimate weapon against glioblastoma, but it needs help

Big news out of the University of Calgary as researchers look at reprogramming the immune system to stop the growth of glioblastoma.


October 2020 –

Midatech Pharma PLC Announces Headline Results of MTX110 Phase I DIPG Study

Midatech Pharma is pleased to announce encouraging headline results from a Phase I study at the University of California, San Francisco in patients with Diffuse Intrinsic Pontine Glioma (“DIPG”).


October 2020 – Precision and Hope – Sunnybrook’s new MR-Linac machine

“Carefully lowering the MR-Linac through the roof of Sunnybrook’s Odette Cancer Centre, and into a specially constructed radiation treatment bunker, was a feat almost as massive as the six-tonne machine itself.”


September 2020 – AstraZeneca says Tagrisso shown to slow lung cancer spreading to brain

Patients diagnosed early enough for certain lung tumours to be surgically removed, and who have a mutation of the so-called EGFR gene, found that Tagrisso cut the risk of developing brain metastases by 82%, a new study shows.


September 2020 – Brain tumour AI helping others

Artificial intelligence (AI) could play a role in diagnosing brain tumours, thanks to a branch of AI called Convolutional Neural Networks (CNN).


September 2020 –

Canadian immunotherapy holds promise for patients with brain cancer

Researchers find that CAR-T therapy can be effective reaching cells that spread from the primary tumour to other parts of the brain.

September 2020 –

Gene therapy provides a potential breakthrough in brain cancer treatment

A new technique of sensitizing stem cells to radiation therapy could have a significant effect on glioblastoma treatment.


September 2020 –

Medexus Reports Health Canada Approval of Gleolan® (5-ALA) for Use in Guided Surgical Resection of High-Grade Gliomas

Gleolan is a substance that makes glioma tumour tissue glow fluorescent under special blue light, and has the potential to greatly increase successful surgical resections.


August 2020 –

Gelareh Zadeh becomes first female chair of neurosurgery at University of Toronto

Congratulations to former Brain Tumour Foundation of Canada award recipient Dr. Gelarah Zadeh on her new appointment as chair of neurosurgery at University of Toronto – the first woman to ever hold the post.


August 2020 –

BioMark Team Secures Health Canada Letter of No Objection for Its Glioblastoma Clinical Trial

“BioMark Diagnostics Inc. is pleased to announce that Health Canada has approved its clinical trial application (CTA) and has granted a Letter of No Objection (NOL) for its application entitled ACETYL-AMANTADINE AS A BIOMARKER IN PATIENTS WITH GLIOBLASTOMA.”


August 2020 –

Gene targeting helps overcome the resistance of brain cancer to therapy

A McGill-led study reveals that suppressing the OSMR gene can improve the effectiveness of radiation therapy in glioblastoma patients.


August 2020 – New drug targets for lethal brain cancer discovered

Researchers engineered a new mouse model for studying glioblastoma, the most aggressive type of brain cancer.


July 2020 –

Five developments in oncology targets

An article exploring some of the newest oncologic drug targets, including those for glioblastoma, lung cancer and breast cancer.


July 2020 –

University and SickKids researchers use common diabetes drug to stimulate repair of brain cells

Researchers and clinicians from the University of Toronto and SickKids Hospital have found that a common diabetes drug may help repair brain injuries.


July 2020 –

UM researchers find new targets for deadly children’s brain tumour

“After discovering how a specific gene fuels a deadly form of children’s brain tumour, University of Manitoba researchers have successfully decreased this cancer in mice.”


July 2020 – Oncogene Responsible for Deadly Glioblastoma Identified

Scientists have identified an oncogene (a cancer-causing gene) responsible for glioblastoma, offering a promising new treatment target for a cancer that is always fatal.


July 2020 – U of T spin-off Empirica Therapeutics acquired by U.S. firm

Empirica Therapeutics, a startup co-founded by Donnelly Centre investigator Jason Moffat and Dr. Sheila Singh, has been acquired by U.S.-based Century Therapeutics.


July 2020 – Researchers discover new strategy to treat brain cancer patients

A new study out of Massachusetts shows that PAR glycohydrolase inhibitors can be used to enhance the effectiveness of chemotherapy in brain tumours.


July 2020 – Deconstructing glioblastoma complexity reveals its pattern of development

For the first time, researchers detected what they describe as a progenitor glioblastoma stem cell (GSC) — a cell type from which all other cancer cells develop – part of five main cancer cell types within each tumour.


July 2020 – Halifax neurosurgeons perform first robot-assisted brain biopsy in Canada

Halifax neurosurgeons are the first in Canada to use cutting-edge robotic technology to perform a brain biopsy.


June 2020 – Bruce Power launches Medical Isotope Advisory Panel

Brain Tumour Foundation of Canada is among a panel of experts and medical professionals dedicated to developing Bruce Power’s isotope program.


June 2020 – Diagnosing brain tumors with a blood test

A simple blood test has been found that accurately diagnosed and classified various brain tumours, opening the door to more accurate diagnoses and less-invasive treatments.


May 2020 – Neuro-oncology management during the COVID19 pandemic with a focus on WHO grades III and IV gliomas

In this consensus statement, an international group of experts present mitigation strategies and treatment guidance for patients suffering from high grade gliomas (HGGs) during the coronavirus disease 2019 (COVID-19) pandemic.


May 2020Genetic Patterns in Brain Cancer Tumors Can Predict Life Expectancy

“For the past 70 years, the best indicator of life expectancy for a patient with glioblastoma (GBM) — the most common and the most aggressive brain cancer — has simply been age at diagnosis.”


May 2020

Health Canada grants market authorization to ROZLYTREK® (entrectinib) for ROS1-positive, locally advanced or metastatic non-small cell lung cancer patients, not previously treated with crizotinib(1)

A new treatment for lung cancer that shows promise in brain metastases.


May 2020Developing microbeam radiation therapy (MRT) for inoperable cancer

High dose x-ray beams – narrower than a human hair – could be used to blast tumours while sparing the surrounding tissue in patients who have expended conventional radiation, thanks to researchers at the University of Saskatchewan.


May 2020Intel, Penn Medicine to co-develop AI tool for identifying brain tumours

Using new technology called ‘federated learning’, artificial intelligence will be able to gather data from participating researchers to help identify brain tumours without compromising the privacy of medical data.


May 2020Study predicts brain tumour response to therapy, could improve patient outcomes

A multi-institutional, international team led by researchers at The Hospital for Sick Children (SickKids) and Baylor College of Medicine, Texas Children’s Hospital has developed a novel approach that delivers appropriately-targeted chimeric antigen receptor (CAR) T cell therapy directly into the cerebrospinal fluid that surrounds the tumor.


May 2020  A promising new treatment for recurrent paediatric brain cancer

A team of researchers have developed a novel methodology to predict, faster, whether or not a metastatic brain tumour would respond to radiotherapy.


May 2020Schizophrenia Drug Combined With Radiation Therapy Improves Overall Survival in Glioblastoma Mouse Model

A combination of radiation and the drug trifluoperazine not only targets glioblastoma cells but also helps overcome the resistance to treatment so common to this aggressive form of cancer. The results could prove promising for patients with the disease, for whom the median survival time is only 12 to 18 months following diagnosis.


April 2020 Nanoparticles offer large potential for brain cancer treatment

A team of researchers for Yale School of Medicine and Beijing Normal University have published a breakthrough study on the use of nanoparticles as a way to deliver drug therapy through the blood-brain barrier.


April 2020 Babies with brain tumors could benefit from targeted treatment

Brain cancer in infants is biologically distinct from other childhood brain tumours and could be successfully treated with targeted drugs, a new study has shown.


April 2020 Understanding brain tumors in children

A European study into the molecular properties of medulloblastoma could lead to more effective treatments in children with certain genetic predispositions.


April 2020 Germline Elongator mutations in Sonic Hedgehog medulloblastoma

By analysing all protein-coding genes, researchers identify and replicate rare germline loss-of-function variants across ELP1 in 14% of paediatric patients with the medulloblastoma subgroup Sonic Hedgehog.


March 2020 Development of new blood tests for GPs could help diagnose brain tumours earlier

The University of Bristol (UK) is leading a project to develop an easy and affordable blood test kit that would have the ability to detect brain tumours. The project explores the use of fluorescent nanomaterials to assist in early diagnostics.


February 2020 Multimillion-grant to speed innovative device for hard-to-treat brain disorders

New research could revolutionize the way doctors tackle hard-to-treat conditions such as brain cancer, ALS and Alzheimer’s, thanks to a landmark $16.7 million grant that will go toward a new type of focused ultrasound device.


February 2020 Computer Simulation Helps Study Brain Cancer Growth

The growth of brain cancers can be better understood with the help of a new computer platform developed by international scientists coordinated by Newcastle University.


February 2020 Cancer vaccine could boost the effectiveness of immunotherapy

Scientists at The Institute of Cancer Research, London, the Mayo Clinic in Rochester, US, and the University of Leeds found that supercharging the mutation rate in cancer cells can create a powerful vaccine that is able to boost the effectiveness of immunotherapy.


February 2020 Bridging the gap between AI and the clinic

Researchers from The Neuro (Montreal Neurological Institute-Hospital) and the Montreal Children’s Hospital of the McGill University Health Centre have developed an open-source app that could bridge machine-learned algorithms with real world clinical practice.


February 2020 Childhood brain cancer: shedding light on tumor origin

A major discovery in the fight against childhood brain cancer has pointed to Peter Pan syndrome as a factor in the foetal development of deadly brain tumours. Peter Pan syndrome refers to the accidental stunting of cells that can then transform into malignant tumours.


February 2020 Robot Brings Companionship to Sick Kids


January 2020 Brain tumours manipulate neighbouring synapses


January 2020 Scientists Breach Brain Barrier To Tackle Tumours


January 2020 A New Treatment for Brain Cancer, Brain cancer: An intelligent molecule to fool and kill glioblastoma cells


January 2020 Brain Tumour Organoids May be Key to Time-sensitive Treatments for Glioblastomas


December 2019 Medicenna Presents Additional Encouraging Phase 2b Clinical Data at the Inaugural Glioblastoma Drug Development Annual Summit


December 2019 Electrospun Fibers Used for Brain Tumor Treatment


December 2019 A potential new treatment for chemotherapy resistant glioblastoma


November 2019 Proton radiotherapy better for pediatric brain cancer patients


November 2019 Glioblastoma incidence rate trends in Canada and the United States compared with England, 1995–2015


November 2019 Kazia Therapeutics shares surge after positive early phase II study results for GDC-0084 in brain cancer patients


November 2019 Air pollution increases risk of brain cancer by 10 per cent, says new Canadian study


November 2019 Lithium can reverse radiation damage after brain tumor treatment


November 2019 UBC expert immobilizes tiny structures linked to metastatic breast cancer


November 2019 Small molecule combats cancer-causing KRAS protein at last


November 2019 The future of immunotherapy for glioblastoma


October 2019 Did you know that circulating tumour cells can target distant organs?


October 2019 Hydrogel that could end chemo for kids with brain cancer: Brigham BRIght Futures Competition


October 2019 Teaming up for brain tumour research


October 2019 Compound Kills Chemotherapy-resistant Cancer Cells


October 2019 ID1 inhibition may improve efficacy of glioblastoma treatment


October 2019 Potential for Fundamental Change in the Treatment of Brain Cancer


October 2019 New blood test uses infrared light, AI to detect signs of brain cancer


October 2019 Alterations to the circadian clock make brain tumours vulnerable


October 2019 New blood test could help hasten the diagnosis of brain tumors


October 2019 ICR Collaborates With AI Drug Discovery Company To Develop Treatments for Rare Childhood Cancer


October 2019 Scientists Create Brain-Mimicking Environment to Grow 3D Tissue Models of Brain Tumors


October 2019 Leukemia drug, Nilotinib, may be useful in treating certain pediatric cancers


September 2019 Cancer cells have the startling ability to behave like neurons


September 2019 Cancer tumours form surprising connections with healthy brain cells


September 2019 Medicenna Presents Promising Update from its MDNA55 Clinical Trial in Recurrent Glioblastoma at the Targeting Innate Immunity Congress


September 2019 U of A researchers move closer to ‘magic’ cancer treatment


September 2019 Mechanism behind glioblastoma survival revealed by study


September 2019 Bayer’s Vitrakvi is first tumour-agnostic drug approved in EU


September 2019 Light-activated metal compound cuts off cancer cell’s ‘power source’


September 2019 Cancer Cells Have “Unsettling” Ability to Hijack the Brain’s Nerves


September 2019 Study reveals neuronal role in glioblastoma growth and how to prevent it


September 2019 Kazia Therapeutics confirms successful completion of phase I study of its childhood cancer drug


September 2019 Two Studies Show Promise, Safety of Proton Therapy in the Brain in Children with Cancer


September 2019 Existing Drug “Blocks” Brain Tumor Growth


September 2019 A diabetes drug promotes brain repair — but it only works in females


September 2019 Novocure Announces 27 Presentations at the American Society for Radiation Oncology 2019 Annual Meeting


September 2019 Message in a brain cell: $7.4M award to decode cues that spur children’s brain tumors


September 2019 Brain tumour detection firm picked for UK-wide AI scale-up programme


September 2019 Bristol-Myers Squibb Provides Update on Phase 3 Opdivo (nivolumab) CheckMate -548 Trial in Patients with Newly Diagnosed MGMT-Methylated Glioblastoma Multiforme


August 2019 New mathematical model can improve radiation therapy of brain tumors


August 2019 Removing cancer’s protective barrier could boost immunotherapy treatments


August 2019 First patient in Canada treated on MR-Linac – Elekta Unity


August 2019 Simple blood test may help detect glioblastoma


August 2019 dentification of genes responsible for sex-related differences in cancer aggressiveness


August 2019 Ziopharm Oncology Announces Publication of Positive Results of Phase 1 Monotherapy Trial of Controlled IL-12 in Patients with Recurrent Glioblastoma in Science Translational Medicine


August 2019 Henry Ford Cancer Institute Enrolls First Patient in World’s Largest Brain Cancer Clinical Trial


August 2019 Brain Cancer Patients Display Decreasing Tumor Biomarkers After Treatment with Novel Immunotherapy in AIVITA Biomedical’s Phase 2 Clinical Trial


August 2019 Immune-Activating Gene Therapy for Gliobastoma


August 2019 Six Western projects earn CFI backing


August 2019 New method to classify brain tumour in children


August 2019 UWindsor researcher gets $100K to study ‘muscle wasting’ in cancer patients


August 2019 Adding MS Drug to Targeted Cancer Therapy may Improve Glioblastoma Outcomes


August 2019 VERZENIO™ (abemaciclib) Available in Canada for Metastatic Breast Cancer 


August 2019 Synaptive launches surgical planning tool for neurosurgeons


August 2019: Could research techniques designed for frogs help spawn a cure for brain tumours?


August 2019: Google maps for tumours and organs


August 2019: Brain Tumour Research’s liquid aspirin study is making headlines


August 2019: Novel nano-vaccine for melanoma developed


August 2019: How artificial intelligence could change the way brain surgeons are trained


August 2019: Machine Learning Identification of Surgical and Operative Factors Associated With Surgical Expertise in Virtual Reality Simulation


August 2019: Artificial Intelligence and Training Physicians to Perform Technical Procedures


August 2019: Bringing Augmented Reality to Brain Surgery


July 2019: MIT “Russian Doll” tech lands $7.9M international award to fight brain tumors


July 2019: HAMLET Pharma Announces Results of First Major Clinical Trial for a New Cancer Killing Molecule


July 2019: Biomaterial-delivered chemotherapy leads to long-term survival in brain


July 2019: Heart drug could increase survival rates for children with aggressive form of brain tumor 


July 2019: Study identifies new potential target in glioblastoma


July 2019: Cancer cells will become vulnerable


June 2019: Tumour treating fields in glioblastoma: Indication of a benefit


June 2019: Reporting from the American Society of Clinical Oncology


June 2019: Medicenna Presents Preliminary Top-Line Clinical Results from their Phase 2b Trial of MDNA55 in Recurrent Glioblastoma 


June 2019: Brain cancer the target of precision medicine research


June 2019: Breaking down the walls of scientific secrecy


June 2019: Artificial nose identifies malignant tissue in brain tumours during surgery


June 2019: Research sheds new light on how brain stem cells are activated 


June 2019: Proton therapy: Cancer revolution or costly white elephant?


June 2019: Pituitary adenomas


June 2019: Medicenna Presents Clinical Validation of the IL4 Receptor as a Biomarker for MDNA55 in Recurrent Glioblastoma 


May 2019: A new home for Sam Weiss brings new hope for brain cancer research 


May 2019: National research team targets glioblastoma


May 2019: Spiders could hold key to ‘smart bandage’ medical treatments: UVic research 


May 2019: ‘I want to help my patients the best I can’


May 2019: Hard knocks for brain cancer, again


May 2019: AbbVie Provides Update on Depatuxizumab Mafodotin (Depatux-M), an Investigational Medicine for Newly Diagnosed Glioblastoma, an Aggressive Form of Brain Cancer


May 2019: Patients at The Neuro benefit from clinical trials


May 2019: Could New Drug Become First Ever Targeted Therapy for “Untreatable” Childhood Brain Cancer?


April 2019: New blood tests to detect brain cancer could be in hospitals within three years


April 2019: Memory could be better protected in kids with brain tumors if treated with proton therapy


April 2019: Viruses that kill bacteria could tackle ‘incurable’ brain cancers


April 2019: Precision medicine for pediatric cancers: New hope for children and adolescents


April 2019: U of T researchers ‘reverse engineer’ brain cancer cells to find new targets for treatment


April 2019: Finding Drivers of Pediatric Brain Cancer Presents Therapeutic Possibilities


April 2019: New clinical trial will determine if gliomas respond to immunotherapy


April 2019: Magnetic nanoparticles can ‘burn’ cancer cells


April 2019: Ziopharm Oncology shares pop after FDA awards fast-track status to brain cancer treatment


March 2019: Bruce Power completes harvest of Cobalt-60 that will save lives through cancer treatments


March 2019: Understanding how people respond to symptoms of a brain tumour


March 2019: Study reveals the evolution of brain tumours


March 2019: Medexus Enters into Expanded Licensing Agreement for Gliolan® in Canada


February 2019: Brain Cancer: Vibrating the brain to find resistant tumours


January 2019: Bruce Power to expand its role in health care


January 2019: U of L researchers studying cells in glioblastoma


January 2019: First-of-its-kind MRI technology coming to Halifax’s QEII